Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Platelet activating factor (PAF) and kidney failure progression]

M Camici, A Carpi, A Sagripanti

    Minerva Medica
    |December 31, 1997
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ocular involvement in monkeypox: Description of an unusual presentation during the current outbreak.

    The Journal of infection·2022
    Same author

    A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
    Same author

    Cell proliferation and drug sensitivity of human glioblastoma cells are altered by the stable modulation of cytosolic 5'-nucleotidase II.

    The international journal of biochemistry & cell biology·2015
    Same author

    The purine analog fludarabine acts as a cytosolic 5'-nucleotidase II inhibitor.

    Biochemical pharmacology·2015
    Same author

    Health promotion in Local Health Unit 4 Chiavarese--Liguria Region, Italy. "Unplugged" project: needs, methodology and implementation.

    Minerva pediatrica·2014
    Same author

    A systemic approach to cancer treatment: tumor cell reprogramming focused on endocrine-related cancers.

    Current medicinal chemistry·2013

    Platelet-activating factor (PAF) plays a key role in renal glomerular pathology. This study investigates how PAF contributes to kidney damage, offering insights into phlogosis mechanisms.

    Area of Science:

    • Nephrology
    • Immunology
    • Pathology

    Background:

    • Inflammation, or phlogosis, involves various mediators impacting kidney glomerular health.
    • Platelet-activating factor (PAF) is implicated as a significant factor in renal glomerular pathology.

    Discussion:

    • This research focuses on elucidating the specific mechanisms through which PAF induces renal glomerular damage.
    • Understanding PAF's role is crucial for developing targeted therapies for kidney diseases.

    Key Insights:

    • PAF appears to be a central mediator in the inflammatory processes leading to glomerular injury.
    • The study aims to detail the molecular pathways affected by PAF in the kidney.

    Outlook:

    • Further research can explore therapeutic strategies targeting PAF to mitigate glomerular damage.

    Related Experiment Videos

  • Findings may inform the treatment of various inflammatory kidney conditions.